Jaime Bartushak
Vermogen: 659 931 $ op 31-05-2026
Vermogen: 659 931 $ op 31-05-2026
Jaime Bartushak is the founder.
Mr. Bartushak was the Chief Financial Officer at Leonard-Meron Biosciences, Inc. since 2014.
Mr. Bartushak is the CFO, Chief Accounting & Business Officer at Citius Pharmaceuticals, Inc. since 2022.
Mr. Bartushak is the Chief Financial Officer & Treasurer at Citius Oncology, Inc. since 2024.
Education includes undergraduate and graduate degrees from New Jersey Institute of Technology.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,89% | 19-09-2025 | 825.000 ( 0,89% ) | 658 350 $ | 31-05-2026 |
| 13-02-2026 | 2.414 ( 0,01% ) | 1 581 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 27-11-2017 |
| Bedrijven | Functie | Einde |
|---|---|---|
Leonard-Meron Biosciences, Inc.
Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company that develops and commercializes critical care products | Oprichter | 01-11-2017 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Operates as a pharmaceutical company | Health Technology |
New Jersey Institute of Technology
New Jersey Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leonard-Meron Biosciences, Inc.
Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company that develops and commercializes critical care products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau